市場調查報告書

無侵入性產前檢查的全球市場:各用途(三染色體症,透納氏症,Rh式血型等),各產品,各技術,各終端用戶,各地區的預測和機會

Global Non-invasive Prenatal Testing Market By Application (Trisomy, Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934728
出版日期 內容資訊 英文 111 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

無侵入性產前檢查的全球市場:各用途(三染色體症,透納氏症,Rh式血型等),各產品,各技術,各終端用戶,各地區的預測和機會 Global Non-invasive Prenatal Testing Market By Application (Trisomy, Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 111 Pages
簡介

無侵入性產前檢查(NIPT),技術的進步和母親的生產年齡上升,以唐氏症,艾德華茲症候群,巴陶氏症等的遺傳性疾病增加的要素為背景實施數量以世界規模增加。現在成為最大的市場,是政府投入高額資金的北美地區,不過,對產前檢查的認識高漲的亞太地區市場今後也將急速成長。

本報告提供全球NIPT市場調查,新型冠狀病毒感染疾病(COVID-19)對市場產生的影響,各地區市場展望,市場力學與趨勢,競爭情形和主要企業的簡介等資訊,同時再加上策略性建議。

目錄

第1章 產品概要

第2章 調查方法

第3章 COVID-19對全球非侵入式的產前檢查(NIPT)市場的影響

第4章 摘要整理

第5章 全球市場的展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途(三染色體症(唐氏症,艾德華茲症候群,巴陶氏症),透納氏症,Rh式血型等)
    • 各產品(設備,套件,化驗)
    • 各技術(無細胞胎兒DNA檢驗,超並列序列,目標捕獲序列等)
    • 終端用戶(醫院,診斷檢驗室)
    • 各企業(2019年)
    • 各地區
  • 市場魅力指數

第6章 亞太地區市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各技術
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第7章 歐洲市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各技術
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利

第8章 北美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各技術
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各技術
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東、非洲市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各技術
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第11章 市場力學

  • 促進促進因素
  • 課題

第12章 市場趨勢

第13章 競爭情形

  • 競爭情形的展望
  • 主要企業的簡介
    • Roche
    • Integrated Genetics
    • Natera
    • BGI Genomics
    • Illumina
    • Invitae
    • Genesis Genomics
    • PerkinElmer
    • Eurofins Scientific
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Yourgene Health
    • Berry Genomics
    • Igenomix
    • Quest Diagnostics
    • Asper Biogene
    • Myriad Genetics
    • Progenity
    • Fasteris
    • Bionet Corp.

第14章 策略性建議

第15章 免責聲明

目錄
Product Code: 4669

Global non-invasive prenatal testing (NIPT) market is expected to witness a robust growth during the forecast period. Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market. Additionally, rise in maternal age and technology advancement have also boosted the demand of NIPT solutions as parents wants to ensure that their baby is free from all disorders and earlier diagnosis assist in that. However, high maintenance and lack of competent professionals are major factors restraining the growth of the market across the globe.

The global non-invasive prenatal testing (NIPT) market is segmented based on application, product, technology, end user and region. The application segment is further segmented into trisomy, turner syndrome, Rh blood type and others, out of which trisomy held the dominant share in 2019 due to the increasing prevalence of Down's syndrome, Edward's syndrome and Patau syndromes in unborn children.

In terms of regional analysis, North America led the market in 2019. The factors responsible for the dominance of North America include heavy funding by the government and presence of leading market players in the region. On the other hand, Asia-Pacific is anticipated to grow at the fastest rate in the coming years due to increasing awareness about prenatal testing among population.

Leading players in the global non-invasive prenatal testing (NIPT) market include Roche, Integrated Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to maintain their position in the market and to generate large revenues, leading players tend to adopt various organic and inorganic strategies like mergers and acquisitions.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global non-invasive prenatal testing (NIPT) market.
  • To classify and forecast global non-invasive prenatal testing (NIPT) market based on application, product, technology, end user and region and company.
  • To identify drivers and challenges for global non-invasive prenatal testing (NIPT) market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global non-invasive prenatal testing (NIPT) market.
  • To conduct pricing analysis for global non-invasive prenatal testing (NIPT) market.
  • To identify and analyze the profile of leading players operating in global non-invasive prenatal testing (NIPT) market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and clinics performing non-invasive prenatal testing across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and clinics performing non-invasive prenatal testing which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and clinics performing non-invasive prenatal testing and presence of all major players across the globe.

TechSci Research calculated the market size of global non-invasive prenatal testing (NIPT) market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Non-invasive prenatal testing (NIPT) hospitals, clinics and laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to non-invasive prenatal testing (NIPT)
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics performing non-invasive prenatal testing, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global non-invasive prenatal testing (NIPT) market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Application:

Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome)

Turner Syndrome

Rh Blood Type

Others

  • Market, By Product:

Instruments

Kits

Assay

  • Market, By Technology:

Cell Free Fetal DNA Technology

Massively Parallel Sequencing

Target Capture Sequences Technology

Others

  • Market, By End User:

Hospitals

Diagnostic Laboratory

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global non-invasive prenatal testing (NIPT) market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Non-Invasive Prenatal Testing (NIPT) Market

4. Executive Summary

5. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome), Turner Syndrome, Rh Blood Type and Others)
    • 5.2.2. By Products (Instruments, Kits and Assay)
    • 5.2.3. By Technology (Cell Free Fetal DNA Technology, Massively Parallel Sequencing, Target Capture Sequences Technology and Others)
    • 5.2.4. By End-User (Hospitals and Diagnostic Laboratory)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Products
    • 6.2.3. By Technology
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Application
        • 6.4.1.2.2. By Products
        • 6.4.1.2.3. By Technology
        • 6.4.1.2.4. By End-User
    • 6.4.2. India Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Application
        • 6.4.2.2.2. By Products
        • 6.4.2.2.3. By Technology
        • 6.4.2.2.4. By End-User
    • 6.4.3. Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Application
        • 6.4.3.2.2. By Products
        • 6.4.3.2.3. By Technology
        • 6.4.3.2.4. By End-User
    • 6.4.4. South Korea Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Application
        • 6.4.4.2.2. By Products
        • 6.4.4.2.3. By Technology
        • 6.4.4.2.4. By End-User
    • 6.4.5. Singapore Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Application
        • 6.4.5.2.2. By Products
        • 6.4.5.2.3. By Technology
        • 6.4.5.2.4. By End-User
    • 6.4.6. Australia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Application
        • 6.4.6.2.2. By Products
        • 6.4.6.2.3. By Technology
        • 6.4.6.2.4. By End-User

7. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Products
    • 7.2.3. By Technology
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Application
        • 7.4.1.2.2. By Products
        • 7.4.1.2.3. By Technology
        • 7.4.1.2.4. By End-User
    • 7.4.2. Germany Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Application
        • 7.4.2.2.2. By Products
        • 7.4.2.2.3. By Technology
        • 7.4.2.2.4. By End-User
    • 7.4.3. United Kingdom Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Application
        • 7.4.3.2.2. By Products
        • 7.4.3.2.3. By Technology
        • 7.4.3.2.4. By End-User
    • 7.4.4. Italy Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Application
        • 7.4.4.2.2. By Products
        • 7.4.4.2.3. By Technology
        • 7.4.4.2.4. By End-User

8. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Products
    • 8.2.3. By Technology
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Application
        • 8.4.1.2.2. By Products
        • 8.4.1.2.3. By Technology
        • 8.4.1.2.4. By End-User
    • 8.4.2. Mexico Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Application
        • 8.4.2.2.2. By Products
        • 8.4.2.2.3. By Technology
        • 8.4.2.2.4. By End-User
    • 8.4.3. Canada Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Application
        • 8.4.3.2.2. By Products
        • 8.4.3.2.3. By Technology
        • 8.4.3.2.4. By End-User

9. South America Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Products
    • 9.2.3. By Technology
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Application
        • 9.4.1.2.2. By Products
        • 9.4.1.2.3. By Technology
        • 9.4.1.2.4. By End-User
    • 9.4.2. Argentina Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Application
        • 9.4.2.2.2. By Products
        • 9.4.2.2.3. By Technology
        • 9.4.2.2.4. By End-User
    • 9.4.3. Colombia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Application
        • 9.4.3.2.2. By Products
        • 9.4.3.2.3. By Technology
        • 9.4.3.2.4. By End-User

10. Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Products
    • 10.2.3. By Technology
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Application
        • 10.4.1.2.2. By Products
        • 10.4.1.2.3. By Technology
        • 10.4.1.2.4. By End-User
    • 10.4.2. Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Application
        • 10.4.2.2.2. By Products
        • 10.4.2.2.3. By Technology
        • 10.4.2.2.4. By End-User
    • 10.4.3. UAE Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Application
        • 10.4.3.2.2. By Products
        • 10.4.3.2.3. By Technology
        • 10.4.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. Roche
    • 13.2.2. Integrated Genetics
    • 13.2.3. Natera
    • 13.2.4. BGI Genomics
    • 13.2.5. Illumina
    • 13.2.6. Invitae
    • 13.2.7. Genesis Genomics
    • 13.2.8. PerkinElmer
    • 13.2.9. Eurofins Scientific
    • 13.2.10. Thermo Fisher Scientific
    • 13.2.11. Agilent Technologies
    • 13.2.12. Yourgene Health
    • 13.2.13. Berry Genomics
    • 13.2.14. Igenomix
    • 13.2.15. Quest Diagnostics
    • 13.2.16. Asper Biogene
    • 13.2.17. Myriad Genetics
    • 13.2.18. Progenity
    • 13.2.19. Fasteris
    • 13.2.20. Bionet Corp.

14. Strategic Recommendations

15. About Us & Disclaimer